Last updated on June 2018

Phase 3 Alogliptin Pediatric Study


Brief description of study

This study will evaluate the efficacy and safety of alogliptin 25 mg once daily (QD) compared to placebo when administered as monotherapy, or when added onto a background of metformin alone, insulin alone, or a combination of metformin and insulin in pediatric participants 10 to 17 years of age with type 2 diabetes mellitus (T2DM).

Detailed Study Description

The drug being tested in this study is called alogliptin. Alogliptin is being tested to treat children 10 to 17 years of age who have type 2 diabetes mellitus (T2DM) and are experiencing inadequate glycemic control. This study will look at glycosylated hemoglobin (HbA1c) fluctuations in children who take alogliptin in addition to their background antidiabetic therapy.

The study will enroll approximately 200 patients. Participants will be randomly assigned (by chance, like flipping a coin) to one of the two treatment groupswhich will remain undisclosed to the patient and study doctor during the study (unless there is an urgent medical need):

  • Alogliptin 25 mg
  • Placebo (dummy inactive pill) - this is a tablet that looks like the tablet containing alogliptin 25mg but has no active ingredient (i.e. has no alogliptin)

All participants will be asked to take one tablet at the same time each day throughout the study in addition to their current background antidiabetic therapy (metformin and/or insulin) if applicable.

This multi-center trial will be conducted worldwide. The overall time to participate in this study is approximately 56 weeks. Participants will make multiple visits to the clinic, and will be contacted by telephone 2 weeks after the last dose of study drug for a follow-up assessment.

Clinical Study Identifier: NCT02856113

Find a site near you

Start Over

Touro University California

Vallejo, CA United States
  Connect »

Ochsner Baptist Medical Center

New Orleans, LA United States
  Connect »

Sherif Khamis

Palmdale, CA United States
  Connect »

Yale New Haven Hospital

New Haven, CT United States
  Connect »

University of Florida

Gainesville, FL United States
  Connect »

Indiana University

Indianapolis, IN United States
  Connect »

University of Iowa

Iowa City, IA United States
  Connect »

University of Kentucky

Lexington, KY United States
  Connect »

Horizon View Medical Center

Las Vegas, NV United States
  Connect »

University of Rochester

Rochester, NY United States
  Connect »

Regional Medical Clinic

Rapid City, SD United States
  Connect »

Baylor College of Medicine

Houston, TX United States
  Connect »

University of Virginia

Charlottesville, VA United States
  Connect »

Seattle Children's Hospital

Seattle, WA United States
  Connect »

Mentrials, SA de CV

Ciudad De Mexico, Mexico
  Connect »

Endo Clinic

Guadalajara, Mexico
  Connect »

Sonomed

Szczecin, Poland
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.